These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 17896550)

  • 1. Stent data show shift in physician preferences.
    Hosp Mater Manage; 2007 Sep; 32(9):8-9. PubMed ID: 17896550
    [No Abstract]   [Full Text] [Related]  

  • 2. Physician preferences will limit ability to lower prices of orthopedics.
    Hosp Mater Manage; 2007 Jul; 32(7):1, 3-5. PubMed ID: 17717879
    [No Abstract]   [Full Text] [Related]  

  • 3. Physician involvement in supply and materials management.
    Rosenstein AH
    Physician Exec; 2004; 30(1):42-8. PubMed ID: 14983704
    [No Abstract]   [Full Text] [Related]  

  • 4. Value and limitations of target-vessel ischemia in predicting late clinical events after drug-eluting stent implantation.
    Zellweger MJ; Kaiser C; Brunner-La Rocca HP; Buser PT; Osswald S; Weiss P; Mueller-Brand J; Pfisterer ME;
    J Nucl Med; 2008 Apr; 49(4):550-6. PubMed ID: 18344439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary artery stents: Part I. Evolution of percutaneous coronary intervention.
    Newsome LT; Kutcher MA; Royster RL
    Anesth Analg; 2008 Aug; 107(2):552-69. PubMed ID: 18633035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of "off-label" utilization of drug-eluting stents on clinical outcomes in patients undergoing percutaneous coronary intervention.
    Roy P; Buch AN; Javaid A; Okabe T; Raya V; Pinto Slottow TL; Steinberg DH; Smith K; Xue Z; Gevorkian N; Satler LF; Kent KM; Suddath WO; Pichard AD; Lindsay J; Waksman R
    Am J Cardiol; 2008 Feb; 101(3):293-9. PubMed ID: 18237587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-eluting coronary stents: many meta-analyses, little benefit.
    Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality following placement of drug-eluting and bare-metal stents for ST-segment elevation acute myocardial infarction in the Global Registry of Acute Coronary Events.
    Steg PG; Fox KA; Eagle KA; Furman M; Van de Werf F; Montalescot G; Goodman SG; Avezum A; Huang W; Gore JM;
    Eur Heart J; 2009 Feb; 30(3):321-9. PubMed ID: 19147604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time dependent vascular and myocardial responses of a second generation, small vessel, paclitaxel-eluting stent platform.
    Thompson CA; Huibregtse B; Poff B; Wilson GJ
    Catheter Cardiovasc Interv; 2009 Apr; 73(5):597-604. PubMed ID: 19180652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The conundrum of late and very late stent thrombosis following drug-eluting stent implantation.
    Garg P; Mauri L
    Curr Opin Cardiol; 2007 Nov; 22(6):565-71. PubMed ID: 17921745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-eluting stents: a critique.
    Melikian N; Wijns W
    Heart; 2008 Feb; 94(2):145-52. PubMed ID: 18195121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restenosis of the CYPHER-Select, TAXUS-Express, and Polyzene-F nanocoated cobalt-chromium stents in the minipig coronary artery model.
    Radeleff B; Thierjung H; Stampfl U; Stampfl S; Lopez-Benitez R; Sommer C; Berger I; Richter GM
    Cardiovasc Intervent Radiol; 2008; 31(5):971-80. PubMed ID: 18095019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Optimal platelet inhibition after coronary stent implantation. Current status].
    Silber S; Hoffmeister HM; Bode C
    Herz; 2008 Jun; 33(4):244-53. PubMed ID: 18581073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late stent thrombosis with drug-eluting stents: the price to pay to prevent restenosis?
    Kumbhani DJ; Bavry AA; Bhatt DL
    Indian Heart J; 2007; 59(2 Suppl B):B113-7. PubMed ID: 19153427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-eluting stent fracture and acute coronary syndrome.
    Chhatriwalla AK; Cam A; Unzek S; Bhatt DL; Raymond RE; Lincoff AM; Whitlow PL; Ellis SG; Tuzcu EM; Kapadia SR
    Cardiovasc Revasc Med; 2009; 10(3):166-71. PubMed ID: 19595398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Off-label use of drug-eluting stents putting it in perspective.
    Grines CL
    J Am Coll Cardiol; 2008 Feb; 51(6):615-7. PubMed ID: 18261679
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug-eluting stents: a comprehensive appraisal.
    Butt M; Connolly D; Lip GY
    Future Cardiol; 2009 Mar; 5(2):141-57. PubMed ID: 19371189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The activity registry of the Hemodynamics and Interventional Cardiology Section in 1992].
    Pan M; Martínez Elbal L; Gómez Recio M; Mainar Tello V
    Rev Esp Cardiol; 1993 Nov; 46(11):711-7. PubMed ID: 8290771
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of drug-eluting stent restenosis: a sandwich may not be the best combo.
    Belardi J
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):599. PubMed ID: 18360848
    [No Abstract]   [Full Text] [Related]  

  • 20. Update on drug-eluting stents.
    Sims JM
    Dimens Crit Care Nurs; 2007; 26(6):237-40. PubMed ID: 18090139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.